This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investors Should Retain Robert Half (RHI) Now
by Zacks Equity Research
Solid liquidity, pro-investor steps and wholly-owned subsidiary Protiviti boost Robert Half (RHI).
Cross Country (CCRN) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Cross Country (CCRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
All You Need to Know About Cross Country (CCRN) Rating Upgrade to Buy
by Zacks Equity Research
Cross Country (CCRN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Cross Country Healthcare (CCRN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Paysign (PAYS) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Paysign, Inc. (PAYS) and Cross Country Healthcare (CCRN) have performed compared to their sector so far this year.
Zacks Investment Ideas feature highlights: Cross Country Healthcare
by Zacks Equity Research
Cross Country Healthcare is part of the Zacks Investment Ideas article.
Funtober: Has the Market Shifted into Rally Mode?
by Bryan Hayes
As stocks bounce from oversold levels, new opportunities are being created in the process - a welcomed sight for bullish investors.
Strength Seen in Cross Country (CCRN): Can Its 8.1% Jump Turn into More Strength?
by Zacks Equity Research
Cross Country (CCRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
The Zacks Analyst Blog Highlights Insperity, Cross Country Healthcare, Resources Connection and Kelly Services
by Santanu Roy
Insperity, Cross Country Healthcare, Resources Connection and Kelly Services are part of Zacks top Analyst Blog.
4 Staffing Stocks to Watch on Solid Job Additions to Economy
by Ritujay Ghosh
The United States has been adding a record number of jobs, helping staffing stocks like Insperity (NSP), Cross Country Healthcare (CCRN), Resources Connection (RGP) and Kelly Services (KELYA).
Cross Country Healthcare (CCRN) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 3.70% and 1.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Cross Country Healthcare (CCRN) Beat on Earnings in Q2?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) second-quarter 2022 earnings and revenues are expected to have increased year over year.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $26.93 in the latest trading session, marking a +0.71% move from the prior day.
Do Options Traders Know Something About Cross Country (CCRN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cross Country (CCRN) stock based on the movements in the options market lately.
Zacks Industry Outlook Highlights Korn Ferry, Cross Country Healthcare and Kelya
by Zacks Equity Research
Korn Ferry, Cross Country Healthcare and Kelya have been highlighted in this Industry Outlook article.
Heidrick & Struggles (HSII) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Heidrick & Struggles (HSII) delivered earnings and revenue surprises of 21.43% and 1.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks to Watch in a Challenging Staffing Services Industry
by Sanjana Goswami
Gradual resumption of business activities, increased dependency on technology, the shift in recruitment patterns within the industry and cost reduction should aid the Zacks Staffing industry. KFY, CCRN and KELYA are well poised to witness a demand surge.
IQVIA (IQV) Beats on Q2 Earnings & Revenues, Alters '22 View
by Zacks Equity Research
IQVIA's (IQV) second-quarter 2022 earnings and revenues surge year over year.
Interpublic Group (IPG) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Interpublic Group's (IPG) second-quarter 2022 earnings and revenues plunge year-over-year.
Equifax (EFX) Beats on Q2 Earnings, Trims 2022 Guidance
by Zacks Equity Research
Equifax's (EFX) second-quarter 2022 earnings and revenues increase year over year.
Omnicom (OMC) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Omnicom's (OMC) second-quarter 2022 earnings increase while revenues decline year over year.
What's in the Offing for IQVIA Holdings (IQV) in Q2 Earnings?
by Zacks Equity Research
IQVIA Holdings' (IQV) second-quarter 2022 earnings and revenues are likely to have risen year over year.
Interpublic (IPG) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Interpublic's (IPG) second-quarter 2022 revenues are likely to rise year over year.
What's in the Offing for Robert Half (RHI) in Q2 Earnings?
by Zacks Equity Research
Robert Half's (RHI) second-quarter 2022 earnings and revenues are likely to have improved on a year-over-year basis.
Equifax (EFX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Equifax's (EFX) second-quarter 2022 earnings and revenues are likely to increase year over year.